KK
Karthik Kuppusamy (SVP, Clinical Solutions) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $1.6M of DGX (8,147 sh × $200.00, as filed), executed Jun 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Jun 4
Filed Jun 8
Median ADV $221.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DGXRecent filings
DGXSALE
Quest Diagnostics Incorporated
View filing →
$1.6M8,147 sh × $200.00
Exec Jun 4
Filed Jun 8 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $538K
2,628 sh × $204.86
Exec Mar 4
Filed Mar 6 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $1.8M
10,479 sh across 3 lots
Exec Jul 30 2025
Filed Aug 1 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $434K
2,555 sh × $170.00
Exec Apr 2 2025
Filed Apr 4 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $279K
1,775 sh × $156.92
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET